GLP-1 Side Effects: A Doctor's Guide to What to Expect and How to Manage Them

Side effects are the most common reason patients consider stopping GLP-1 therapy. The irony is that most side effects are manageable — often resolving on their own within weeks — if you know what to expect and how to respond. The key is clinical guidance, not guesswork.

This guide covers the most common GLP-1 side effects, what causes them, and the evidence-based strategies doctors use to manage them.

Gastrointestinal Side Effects — The Big Three

Nausea (40–50% of patients)

The most frequently reported side effect, particularly during titration. GLP-1 agonists slow gastric emptying — food stays in your stomach longer, which can trigger nausea, especially after large or fatty meals.

Management strategies:

• Eat smaller, more frequent meals rather than large portions.
• Avoid high-fat, greasy, or heavily spiced foods during dose escalation.
• Eat slowly and stop before feeling full — your satiety signals are amplified.
• Stay upright for 30+ minutes after eating.
• Your provider may prescribe ondansetron (Zofran) for persistent nausea during titration.

Constipation (20–30% of patients)

Slowed gastric motility can extend through the entire digestive tract. Reduced food intake compounds the issue — less food in means less fiber, less bulk, less movement.

Management: Increase water intake (aim for 64+ oz daily), add fiber-rich foods or a fiber supplement, and consider osmotic laxatives (MiraLAX) if dietary changes aren't sufficient. Regular physical activity also helps.

Diarrhea (15–25% of patients)

Less common than nausea and constipation but can occur, particularly at higher doses. Often alternates with constipation in some patients.

Management: Monitor hydration closely, adjust fat intake (dietary fat malabsorption can worsen diarrhea), and report persistent symptoms to your provider.

Injection Site Reactions

Mild redness, swelling, or itching at the injection site occurs in roughly 5–10% of patients. This is typically self-limiting and can be minimized by rotating injection sites (abdomen, thigh, upper arm) and allowing the medication to reach room temperature before injecting.

Fatigue and Low Energy

Some patients report fatigue, particularly in the first month. This often correlates with reduced caloric intake rather than a direct drug effect. When you're eating significantly less, your body adjusts its energy expenditure. Ensuring adequate protein intake (0.7–1.0g per pound of lean body mass) and maintaining hydration can help.

Headaches

Reported in 10–15% of patients, usually during the first few weeks. Often related to dehydration or caloric reduction rather than direct pharmacological effect. Adequate fluid intake typically resolves them.

Serious Side Effects — Rare but Important

• Pancreatitis (rare, <1%): Severe, persistent abdominal pain radiating to the back — especially after eating — warrants immediate medical attention. Discontinue the medication and seek care.
• Gallbladder disease: Rapid weight loss increases gallstone risk regardless of the method. Symptoms include right upper abdominal pain after fatty meals.
• Thyroid concerns: The boxed warning regarding thyroid C-cell tumors is based on rodent studies at doses far exceeding human therapeutic levels. No causal link has been established in humans, but the warning exists for transparency.
• Hypoglycemia: Rare when GLP-1 agonists are used alone. Risk increases when combined with insulin or sulfonylureas in patients with diabetes.

When to Call Your Doctor

• Severe abdominal pain that doesn't resolve
• Persistent vomiting preventing fluid intake for 24+ hours
• Signs of dehydration: dark urine, dizziness, rapid heart rate
• Allergic reaction: rash, swelling, difficulty breathing
• Any symptom that feels significantly different from your normal adjustment